scholarly journals Response to savolitinib (AZD6094/HMPL-504, a potent and selective MET inhibitor) in a papillary renal cell carcinoma patient harbouring a novel MET activating mutation

2016 ◽  
Vol 27 ◽  
pp. vi535
Author(s):  
M.M. Frigault ◽  
D. Stetson ◽  
E. Maloney ◽  
J.F. Kramkowski ◽  
E. Barry ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Papillary Renal Cell Carcinoma ◽  
Renal Cell Carcinoma Patient ◽  
Carcinoma Patient ◽  
Activating Mutation ◽  
Met Inhibitor

Rare anti-VEGFR therapy-induced toxicity and long-term response to immunotherapy in a rare non-clear cell renal cell carcinoma patient

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Fabio Catalano ◽  
Sara Elena Rebuzzi ◽  
Veronica Murianni ◽  
Alessandra Damassi ◽  
Valentino Martelli ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Clear Cell ◽  
Renal Cell Carcinoma Patient ◽  
Cell Renal Cell Carcinoma ◽  
Carcinoma Patient ◽  
Term Response

scholarly journals Dll4 Blockade Potentiates the Anti-Tumor Effects of VEGF Inhibition in Renal Cell Carcinoma Patient-Derived Xenografts

PLoS ONE ◽  
2014 ◽  
Vol 9 (11) ◽  
pp. e112371 ◽  
Author(s):  
Kiersten Marie Miles ◽  
Mukund Seshadri ◽  
Eric Ciamporcero ◽  
Remi Adelaiye ◽  
Bryan Gillard ◽  
...  
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Renal Cell Carcinoma Patient ◽  
Carcinoma Patient ◽  
Vegf Inhibition

scholarly journals Lung Aspergillosis in renal cell carcinoma patient treated with sunitinib

QJM ◽  
2011 ◽  
Vol 105 (7) ◽  
pp. 689-692 ◽  
Author(s):  
E. E. Visvardis ◽  
F. Gao ◽  
M. N. Paes ◽  
O. Duprez ◽  
J. Waxman
Keyword(s):  
Renal Cell Carcinoma ◽  
Cell Carcinoma ◽  
Renal Cell ◽  
Renal Cell Carcinoma Patient ◽  
Carcinoma Patient
Sign in / Sign up

Export Citation Format

Share Document